Tci Wealth Advisors, Inc. Glaukos Corp Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$34.86 - $63.77 $2,649 - $4,846	76 Added 42.7%	254 $12,000
Q4 2021 Jan 24, 2022	BUY	$40.27 - $56.99 $1,610 - $2,279	40 Added 28.99%	178 $8,000
Q3 2021 Oct 29, 2021	BUY	$47.43 - $84.23 $1,185 - $2,105	25 Added 22.12%	138 $7,000
Q2 2021 Aug 02, 2021	BUY	$73.06 - $97.7 $2,703 - $3,614	37 Added 48.68%	113 $10,000
Q1 2021 Apr 29, 2021	BUY	$70.43 - $97.42 $3,028 - $4,189	43 Added 130.3%	76 $6,000
Q1 2020 Apr 14, 2020	BUY	$25.53 - $70.14 $842 - $2,314	33 New	33 $1,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.